Insights & Industry Knowledge.
Explore the latest articles on pharmaceutical exports, cold chain logistics, regulatory compliance, and global healthcare supply chains.
Global Healthcare News
Curated, worldwide headlines on pharmaceuticals, medicines, clinical research, biotechnology, and global health — sourced from independent news outlets and linked back to the original article.
OneSource Specialty Pharma to attend Jefferies Global Healthcare Conference
OneSource Specialty Pharma will attend the Jefferies Global Healthcare Conference in London from November 16 to 19, 2026. Representatives will discuss business overview, strategy, and industry trends using only publicly available information. The filing confirms no unpublished price sensitive information (UPSI) will be shared during the investor interactions.
6 Ways Investors Can Cash in on Bouncing Healthcare Stocks
Boosted mainly by biotech, the healthcare sector is recuperating from its years-long malaise.
Essar eyes $18-billion US steel plant: Why Indian firms are investing in US amid tariffs
While Essar Group’s investment pledge is one of the largest in the last few months, several Indian companies are boosting investment in the US. These include JSW Steel and Sun Pharmaceutical. What's behind this?
Professor Bill Sessa, Former Chief Scientific Officer of Internal Medicine at Pfizer, Appointed Chair of Isomab's Scientific Advisory Board
/PRNewswire/ -- Isomab Ltd ("Isomab") a UK-based biotechnology company developing novel therapies to restore vascularization in cardiovascular disease, today...
WHO and partners discuss governance of traditional medicine knowledge in the AI era at WIPO-IGC
From second left to right: Dr. Suerie Moon, James Love, Ambassador Guilherme de Aguiar Patriota, Peter Harrison, Margo A Bagley©WHOBringing together experts from international organizations, academia, governments and civil society, WHO-KEI (Knowledge Ecology International) co-organized an event on the sidelines of 53rd Inter Government Consultations (IGC) at World Intellectual Property Organization (WIPO) on 22 September 2026. It explored how intellectual property, access and benefit-sharing and data governance frameworks can support innovation in traditional medicine while safeguarding the rights of Indigenous Peoples and local communities. At the side event, Intellectual Property and Traditional Medicine: Rethinking Access, Benefit Sharing and Data Governance, speakers examined the implications of digitalization, artificial intelligence and evolving international policy frameworks for traditional medicine knowledge. Dr Suerie Moon, Co-Director, Global Health Centre, Graduate Institute, moderated the expert panel. She lauded the organizers for convening this event on a "very timely topic" dealing with the "rapid change in technologies, as well as the normative and legal landscape". Opening the discussion, Manjeet Singh Saluja of the WHO Global Traditional Medicine Centre highlighted the need to advance traditional medicine that is safe, effective and evidence-informed while protecting traditional medicine knowledge, recognizing the rights of Indigenous Peoples and local communities, and safeguarding biodiversity. He outlined WHO initiatives, including an intellectual property toolkit for traditional medicine and a framework for respectful knowledge exchange with Indigenous Peoples. Panelists emphasized that artificial intelligence (AI) and digital technologies are creating new opportunities for research and innovation while also raising questions about attribution, ownership, consent and equitable benefit-sharing. Margo A. Bagley of Emory University noted that AI could accelerate drug discovery based on traditional medicine knowledge but may also make it more difficult to trace contributions made by knowledge holders. James Love, Director of KEI presented findings from two draft WHO papers on the legal and IP considerations for traditional medicine databases, including the challenge of protecting community rights across jurisdictions. He proposed federated data governance and tailored benefit-sharing arrangements to support trusted evidence generation and equitable remuneration. Reflecting on the recently adopted WIPO Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge, Guilherme de Aguiar Patriota, Ambassador of Brazil to the World Trade Organization (WTO), described the agreement as a major step toward greater transparency and recognition of Indigenous Peoples and local communities within the international intellectual property system. He stressed the importance of securing ratifications and effective implementation. Speakers also discussed governance models for traditional medicine databases, the role of prior informed consent and approaches to equitable benefit-sharing. Throughout the discussion, participants underscored that Indigenous Peoples and local communities should be recognized not merely as sources of knowledge, but as partners in its stewardship and governance. Closing the event, Manjeet Singh Saluja emphasized that responsible governance should respect community rights and authority, preserve attribution and provenance, support equitable benefit-sharing, and ensure responsible and traceable data governance. The moderator, Dr Moon, thanked WHO and KEI for flagging the complexity of the ecosystem of IP and traditional medical knowledge while advancing "concrete proposals". Watch the webinar>>
Knight Therapeutics Enters into Exclusive Distribution Agreement with Kyowa Kirin International for Poteligeo® (Mogamulizumab)
MONTREAL, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. ("Knight") (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced
Where every crisis becomes visible
As conflict, climate change and disease converge on the same overwhelmed clinics, Dr Maíra Fedatto of Action for Global Health argues the new UK Government has a rare chance to lead differently
Sun Pharma agrees to lower US drug prices under Trump plan; analysts see limited financial impact
Sun Pharmaceutical Industries will offer its drugs at prices matching other developed nations. This agreement aims to make healthcare affordable for low-income Americans. Analysts believe the financial impact on Sun Pharma will be minimal. The company's US revenue contribution is significant, reinforcing its growth strategy. This pact recognizes Sun Pharma's investment in the American market.
What Trump's Most-Favored-Nation Deal Means for Drug Prices
A deal with pharmaceutical companies may not be as far-reaching as the administration says, according to experts.
Articles
Insights that move healthcare
A curated selection of logistics, regulatory, and industry insights built to last, designed to perform, and empower your global healthcare reach.
First Affordable Teriparatide Injection Biosimilar Will Enter the Philippine Market
Getmeds, a trusted provider of affordable cancer, hematology, and anesthesia products, is taking a meaningful step forward by offering the most cost-effective teriparatide injection pen biosimilar in the Philippine market.
How to Get Medical Assistance from DSWD: Your 2025 Ultimate Guide
Ang Kagawaran ng Kagalingan at Pagpapaunlad Panlipunan o Department of Social Welfare and Development (DSWD) ay isang ahensya ng gobyerno na namamahala sa pagbuo, pagtupad, at pag-coordinate ng mga…
9 Affordable and Healthy Filipino Foods That Help Reduce Cancer Risk Budget Friendly Alternatives
More than being physically fit and keeping your body in shape, ensuring that you’re eating healthy with cancer-fighting food as you’re undergoing chemotherapy and taking other prescribed cancer medicines is beneficial for the entirety of your well-being.
Getmeds Salute Cancer Warriors: Free Live Q&A with a Doctor This April – Get Your Questions Answered!
Las Pinas City, Philippines — With its ongoing support for cancer patients and the importance of making healthcare information accessible to all, Getmeds Philippines Inc. invites you to a free virtual question and answer for cancer patients to be held this April 2025.
Life-Changing Tips for Managing Chemotherapy Side Effects in 2025: What to Do Before, During, and After Treatment
Chemotherapy side effects may vary from person to person, but there are a couple of common ones that patients often always get to experience as they’re taking their cancer care medicines or undergoing their cancer treatments.
20 Cancer Myths and Misconceptions You Should Stop Believing in 2025
Cancer myths and misconceptions is a topic discussion that continues to be passed around without much caution or the need to fact check by the people, prompting misleading content to be disseminated more.
7 Proven Ways Contraceptive Pills Help Manage PCOS
Contraceptive pills for PCOS (polycystic ovary syndrome) management have been commonly recommended by gynaecologists as a first-line treatment, as well as for other hormonal conditions like abnormal menstruation, dysmenorrhea, and premenstrual syndrome.
How to Lower Cancer Risk in Women: 12 Easy Ways to Stay Healthy
Cancer risk factors in women often stem from a combination of their family’s medical history, environmental exposures, unhealthy lifestyle choices, and genetic mutations.
More Filipino Women Are Choosing to Use Contraceptives — New CPD Data Reports
Cancer risk factors in women often stem from a combination of their family’s medical history, environmental exposures, unhealthy lifestyle choices, and genetic mutations.